Découvrez l’unité RIGHT

    UMR RIGHT

    RIGHT (Regulation of Immunity for therapeutic innovation in Graft, Host, Tumoral and inflammatory associated diseases) is interested in the immunological relationships
    between a patient and his graft or his tumor. A better understanding of these interactions allows the development of new treatments based on cell and gene therapy approaches
    to modulate the immune system in order to prevent graft rejection or, on the contrary, to induce tumor elimination. The modulation of chronic inflammatory diseases by
    biotherapies (complex biological drugs) is also a research axis of the unit. Right is also interested in the identification of biomarkers in chronic inflammatory diseases and
    cancers.

    UMR RIGHT works in several areas of medical research such as :

     

    • Immune responses
    • Physiopathology of autoimmune diseases
    • Complications related to transplantation (bone marrow, kidney)
    • Blood transfusion
    • Autophagy and the anti-tumor immune response
    • Anti-cancer immunotherapies (peptide vaccination, CAR-T cells, transgenic TCR)
    • Biomarkers

     

     

    Located in the TEMIS health cluster of the Hauts du Chazal in Besançon, UMR RIGHT is involved in :

     

    RIGHT is also a partner of BioNoveo, the business unit of the FRANCHE-COMTE’INNOV partnership foundation.

     

    Concerned about the quality of its work, UMR RIGHT is committed to a quality approach and has been ISO 9001 certified since June 2012.

    En savoir plus >